ENTITY

Medexus Pharmaceuticals (MEDXF US)

17
Analysis
Health Care • Canada
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
more
•04 Mar 2025 12:33

Best Ideas of 2025

The range of ideas is broad. The smallest market cap is a $15MM Canadian micro-cap that is trading below its net cash, and the largest is an $25BN...

Logo
599 Views
Share
•17 Aug 2026 10:43

Weekly Update (MSGS, MEDXF, REZI)

Analysts almost always start high and walk it down. Since 2001, consensus S&P 500 calendar-year EPS estimates have drifted about 4.0% lower over...

Logo
122 Views
Share
•15 Jun 2026 10:10

Weekly Update (HONA, HON, MEDXF)

This week, all eyes were on the SpaceX (SPCX) IPO, which priced at $135 per share — an implied $1.77 trillion valuation and the largest debut in...

Logo
98 Views
Share
bullish•Western Digital
•13 Jul 2026 11:03

Live Call Starts in 1 Hour! + Weekly Update (CMCSA, MFP, HONA, MBGL)

Western Digital (WDC) remains volatile, with large swings driven by investor enthusiasm for the AI trade. I continue to believe there is...

Logo
110 Views
Share
bullish•NE Inc
•29 Jun 2026 10:03

Weekly Update (MBGL, 441A, MEDXF)

Last week, I noted that the second half of June is typically a weak period for the stock market. Right on cue, the S&P 500 sold off 1.95%.

Logo
116 Views
Share
x